Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20050040HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS20045630HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS20065901HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS20027492HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS20037070HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS20045213HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44002387HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44001616HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44020408HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS44026578HTLV-1ENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TCGA Plot Options
Drug Information
GeneKCNQ1
DrugBank IDDB11633
Drug NameIsavuconazole
Target IDBE0000672
UniProt IDP51787
Regulation Typeinhibitor
PubMed IDs28074556
CitationsKeirns J, Desai A, Kowalski D, Lademacher C, Mujais S, Parker B, Schneidkraut MJ, Townsend R, Wojtkowski T, Yamazaki T, Yen M, Kowey PR: QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization. Clin Pharmacol Ther. 2017 Jun;101(6):782-790. doi: 10.1002/cpt.620. Epub 2017 Feb 13.
GroupsApproved; Investigational
Direct ClassificationPhenylpropanes
SMILESC[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Pathways
PharmGKB
ChEMBLCHEMBL409153